IRVINE, CALIFORNIA, November 23, 2015 – Inari Medical, Inc. and Inceptus Medical LLC announced today that the Inari FlowTriever® Retrieval /Aspiration System for thrombectomy received a 1st place Innovation Award at the 2015 Transcatheter Therapeutics (TCT) conference in San Francisco.

“We are pleased to have the FlowTriever thrombectomy system showcased at such a large and prestigious venue as TCT,” says Bill Hoffman, President and CEO of Inari. Bob Rosenbluth, President of Inceptus added, “We are proud to have Inari get this recognition at the largest medical device conference for interventional therapy. This is a nice honor as we initiate our pivotal trial to investigate the use of the FlowTriever specifically for the treatment of pulmonary embolism.”

About Inari Medical, Inc.
Inari Medical, Inc. is a dedicated to the development of innovative catheter-based technologies for the interventional treatment of vascular thrombus and emboli, focusing on large volume clot removal from large vessels. The FlowTriever system provides a new approach to thrombectomy without the need for thrombolytics. The FlowTriever is 510(k) cleared for thrombectomy in the peripheral vessels. Use for the treatment of pulmonary embolism is investigational; the device has not been cleared in the United States for this specific use. Inari Medical, founded in 2013, is a venture capital backed medical device company formed by Inceptus Medical. The company is backed by Versant Ventures, U.S. Venture Partners, the founders, and other private investors. For more information, please visit

About Inceptus Medical LLC
Inceptus is a medical device incubator with a mission to create and nurture innovative concepts into companies by providing a combination of experienced engineering, clinical research expertise, seasoned leadership and strong financial resources. Inceptus was founded by serial entrepreneurs Bob Rosenbluth, Brian Cox and Paul Lubock. The principals of Inceptus were founders of several successful medical device startup companies including Microvention (now part of Terumo), Sequent Medical, SenoRx (now part of CR Bard) and Inari. For more information, please visit

Bill Hoffman, Chief Executive Officer, Inari Medical Inc.
Ph. 949-600-8433
Fx. 949-242-2535